Q32 Bio Inc. (QTTB) Retained Earnings (2017 - 2026)

Q32 Bio has reported Retained Earnings for 10 years, with the latest figure at $327.4 million in Q2 2026.

• On a quarterly basis, Retained Earnings rose 228.24% year-over-year to $327.4 million in Q2 2026; TTM through Jun 2026 was $327.4 million, a 228.24% increase from a year earlier, with the FY2025 full-year figure at $247.0 million, up 2.71% from the prior year.
• Retained Earnings was $327.4 million for Q2 2026 at Q32 Bio, up from $258.9 million in the prior quarter.
• The five-year high for Retained Earnings was $614.2 million in Q3 2023, with the low at -$429.1 million in Q4 2022.
• Average Retained Earnings over 5 years is $64.0 million, with a median of $235.7 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Retained Earnings soared 283.74% in 2023, then slumped 209.96% in 2025.
• Over 5 years, Retained Earnings stood at -$429.1 million in 2022, then surged by 56.41% to -$187.1 million in 2023, then surged by 228.55% to $240.5 million in 2024, then increased by 2.71% to $247.0 million in 2025, then soared by 32.57% to $327.4 million in 2026.
• The last three Retained Earnings figures came in at $327.4 million (Q2 2026), $258.9 million (Q1 2026), and $247.0 million (Q4 2025), per Business Quant data.